NO961995L - Anvendelse av IGF-BP for renaturering av IGF - Google Patents

Anvendelse av IGF-BP for renaturering av IGF

Info

Publication number
NO961995L
NO961995L NO961995A NO961995A NO961995L NO 961995 L NO961995 L NO 961995L NO 961995 A NO961995 A NO 961995A NO 961995 A NO961995 A NO 961995A NO 961995 L NO961995 L NO 961995L
Authority
NO
Norway
Prior art keywords
igf
insulin
growth factor
renaturation
binding protein
Prior art date
Application number
NO961995A
Other languages
English (en)
Other versions
NO961995D0 (no
Inventor
Bjorn Nilsson
Sophia Elisabeth Hober
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO961995L publication Critical patent/NO961995L/no
Publication of NO961995D0 publication Critical patent/NO961995D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Anvendelse av insulinlignende vekstfaktorbindingsprotein (IGF-BP) for refolding av insulinlignende vekst- faktor (IGF). Bindingsproteinet er for- trinnsvis hvilken som helst av IGF-BP- 1, IGF-BP-2, IGF-BP-3, IGF-BP-4, IGF- BP-5 eller IGF-BP-6 og den insulin- lignende vekstfaktoren er fortrinnsvis IGF-I. En fremgangsmåte for fremstil- ling av biologisk aktiv, nativ IGF-I eller IGF-II, kjennetegnet ved at IGF-I eller IGF-II i redusert eller misfoldet utgave behandles med IGF-BP, er også besrekvet.
NO961995A 1993-11-16 1996-05-15 Anvendelse av IGF-BP for renaturering av IGF NO961995D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303784A SE9303784D0 (sv) 1993-11-16 1993-11-16 Igf
PCT/SE1994/001076 WO1995014034A1 (en) 1993-11-16 1994-11-14 Use of igf-bp for refolding of igf

Publications (2)

Publication Number Publication Date
NO961995L true NO961995L (no) 1996-05-15
NO961995D0 NO961995D0 (no) 1996-05-15

Family

ID=20391767

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961995A NO961995D0 (no) 1993-11-16 1996-05-15 Anvendelse av IGF-BP for renaturering av IGF

Country Status (12)

Country Link
US (1) US5683980A (no)
EP (1) EP0736040B1 (no)
JP (1) JP3609410B2 (no)
AT (1) ATE190627T1 (no)
AU (1) AU684117B2 (no)
CA (1) CA2176599A1 (no)
DE (1) DE69423516T2 (no)
FI (1) FI962081A7 (no)
NO (1) NO961995D0 (no)
NZ (1) NZ276520A (no)
SE (1) SE9303784D0 (no)
WO (1) WO1995014034A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
JP3734634B2 (ja) * 1999-03-03 2006-01-11 ヒゲタ醤油株式会社 タンパク質の活性化方法及び該装置
KR20020074749A (ko) * 2001-03-21 2002-10-04 한국생명공학연구원 재조합 인슐린 유사성장인자-1의 대량 생산방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
WO1992014834A1 (en) * 1991-02-14 1992-09-03 The Whittier Institute For Diabetes And Endocrinology Insulin-like growth factor binding protein
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
WO1993019084A1 (en) * 1992-03-24 1993-09-30 Synergen, Inc. Refolding and purification of insulin-like growth factor i
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury

Also Published As

Publication number Publication date
EP0736040B1 (en) 2000-03-15
FI962081L (fi) 1996-07-15
FI962081A0 (fi) 1996-05-15
WO1995014034A1 (en) 1995-05-26
DE69423516T2 (de) 2000-09-14
CA2176599A1 (en) 1995-05-26
DE69423516D1 (de) 2000-04-20
EP0736040A1 (en) 1996-10-09
JP3609410B2 (ja) 2005-01-12
US5683980A (en) 1997-11-04
FI962081A7 (fi) 1996-07-15
NZ276520A (en) 1997-11-24
AU684117B2 (en) 1997-12-04
ATE190627T1 (de) 2000-04-15
NO961995D0 (no) 1996-05-15
AU1080895A (en) 1995-06-06
JPH09505077A (ja) 1997-05-20
SE9303784D0 (sv) 1993-11-16

Similar Documents

Publication Publication Date Title
DK0429570T3 (da) Osteoinducerende præparater
DK1100529T3 (da) Thymosin beta 4 fremmer sårheling
MX9701916A (es) Procedimiento para la investigacion de la interaccion de biomoleculas mediante resonancia de plasmones en la superficie.
ATE114156T1 (de) Herstellung von proteinen in aktiver form.
NO984345L (no) FremgangsmÕte for vevsinduksjon ved anvendelse av en kombinasjon av benmorfogenisk protein og paratyroid hormon-relatert peptid
ATE125869T1 (de) Wachstumshormonfusionsproteine.
DE69125394D1 (de) Behandlung von osteoporose unter verwendung von wachstumshormon-freisetzendem faktor (grf) in verbindung mit parathyroidhormon (pth)
DE68923556D1 (de) Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes.
DK0661990T3 (da) Fremgangsmåde til systemisk behandling af kataboliske tilstande og systemisk vævsbeskadigelse
DE69523611D1 (de) Neues verfahren für die produktion von biologisch aktivem protein (tgf)
NO961995L (no) Anvendelse av IGF-BP for renaturering av IGF
ATE207933T1 (de) Verfahren zur herstellung vom aktieven protein dimerischen
DE69018799D1 (de) IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie.
GR3030947T3 (en) Selective system scan for multizone radiotelephone subscriber units.
ATE243712T1 (de) Vekürztes insulinähnlichen wachstumsfaktor- bindendes protein mit mitogener aktivität
DE69231036D1 (de) Verfahren zur behandlung von patienten mit chronischer lebererkrankung
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
ATE261985T1 (de) Verfahren zur herstellung von richtig gefaltetem, biologisch aktivem, rekombinantem protein
SE9303068D0 (sv) New use
ATE110961T1 (de) Behandlung von beatmungsabhängigkeit mit wachstumshormon.
DE69126180D1 (de) Behandlung polyzystischer ovarkrankheit
DK194990D0 (da) Aldc-derivat og anvendelse deraf
GR3025246T3 (en) METHOD FOR PREPARING A PROTEIN SELECTED FROM THE CYTOKINE GROUP, COMPRISING AT LEAST ONE INTRAMOLECULAR DISULPHIDE BOND BY OXIDATION, AT A pH OF LESS THAN 5.0, OF THE REDUCED RECOMBINANT PROTEIN
MX9710291A (es) Inhibidores ligantes de proteinas de fijacion con factor de crecimiento del tipo de insulina y metodos de uso para los mismos.
DK0484429T3 (da) Fremgangsmåde til behandling af infertilitet eller sub-fertilitet hos voksne mænd, og brugen af præparater til fremgangsmåden